|
HS Code |
622074 |
| Productname | 3-(Trifluoromethyl)Benzamidoxime |
| Casnumber | 223636-33-5 |
| Molecularformula | C8H7F3N2O |
| Molecularweight | 204.15 |
| Appearance | White to off-white solid |
| Purity | Typically ≥98% |
| Meltingpoint | 133-137°C |
| Solubility | Slightly soluble in water, soluble in organic solvents |
| Smiles | C1=CC(=CC(=C1)C(F)(F)F)C(=N)NO |
| Inchi | InChI=1S/C8H7F3N2O/c9-8(10,11)6-3-1-2-5(4-6)7(12)13-14/h1-4,14H,(H2,12,13) |
| Storageconditions | Store at 2-8°C, keep container tightly closed |
| Synonyms | 3-(Trifluoromethyl)benzamidine oxime |
As an accredited 3-(Trifluoromethyl)Benzamidoxime factory, we enforce strict quality protocols—every batch undergoes rigorous testing to ensure consistent efficacy and safety standards.
| Packing | The packaging includes a 10g amber glass vial, tightly sealed, with clear labeling displaying "3-(Trifluoromethyl)Benzamidoxime," safety warnings, and batch details. |
| Shipping | **Shipping Description for 3-(Trifluoromethyl)Benzamidoxime:** This chemical is shipped in tightly sealed containers to prevent moisture and contamination. It should be transported at room temperature, protected from light and incompatible substances. Proper chemical labeling and handling according to MSDS and relevant regulations are required to ensure safe delivery. Keep away from oxidizers and acids. |
| Storage | Store **3-(Trifluoromethyl)benzamidoxime** in a cool, dry, and well-ventilated area, in a tightly sealed container. Protect from moisture, heat, and direct sunlight. Keep away from incompatible substances such as strong oxidizing agents and acids. Ensure proper labeling and avoid sources of ignition. Follow all relevant chemical hygiene and safety protocols during handling and storage. |
Applications of 3-(Trifluoromethyl)Benzamidoxime in Industrial Manufacturing3-(Trifluoromethyl)Benzamidoxime serves as a specialized intermediate across chemical and pharmaceutical manufacturing, supporting high-value syntheses where selectivity, stability, and fluorinated functionality enhance final product performance and compliance. The following sections detail its specific applications, industrial integration, and compliance landscape for each downstream sector. 1. Active Pharmaceutical Ingredient (API) Synthesis for Antiviral CompoundsAdvanced pharmaceutical producers incorporate 3-(Trifluoromethyl)Benzamidoxime as a protected amidoxime synthon to introduce fluorinated fragments crucial for improving pharmacokinetics and target affinity in antiviral drug molecules. Formulation chemists leverage its nucleophilicity during the construction of heterocyclic motifs, with exact molar input ranging by targeted scaffold. The material undergoes strict trace impurity control during the multistep synthetic route, entering at key cyclization or functionalization steps following GMP validation and analytical qualification. End products include drug substances for direct formulation into oral and injectable antiviral medications. Industry compliance standards
Typical usage ratio
Downstream process integration
Final product types
2. Agrochemical Active Ingredient DevelopmentIn the agrochemical sector, leading R&D and scale-up groups use 3-(Trifluoromethyl)Benzamidoxime to build trifluoromethylated heterocyclic cores in new-generation herbicidal and fungicidal compounds. Its inclusion increases lipophilicity and environmental persistence as required by specific regulatory dossiers. Technical teams manage its controlled addition during functionalization steps, ensuring batch-to-batch uniformity and residue compliance. Strict documentation and trace contaminant checks integrate with downstream formulation protocols yielding stable, registered active ingredients. Industry compliance standards
Typical usage ratio
Downstream process integration
Final product types
3. Specialty Electronic Chemical Synthesis for Liquid Crystal CompoundsManufacturers developing custom liquid crystal materials for display applications add 3-(Trifluoromethyl)Benzamidoxime for targeted molecular design where trifluoromethyl groups enhance dielectric anisotropy and molecular alignment. Process engineers tightly control its concentration to minimize residual contaminants that could affect display lifetime and electro-optical response. The raw material enters alkylation or aryl amidoxime modifications preceding the final condensation of liquid crystalline phases. Finished blends pass rigorous quality analytics before integration into consumer and industrial electronic screens. Industry compliance standards
Typical usage ratio
Downstream process integration
Final product types
4. Synthesis of Fluorinated Polymer Precursors for Performance MaterialsProducers of high-performance fluorinated polymers use 3-(Trifluoromethyl)Benzamidoxime as a nucleophilic intermediate, facilitating introduction of trifluoromethyl units that yield enhanced chemical resistance and reduced surface energy in end-use materials. Polymer scientists dose the material precisely during pre-polymer or chain-extender preparation, where reaction parameters such as temperature, pH, and solvent system directly influence purity and structural integration. Post-synthesis, strict filtration and volatile removal prepare concentrates that serve as starting points for next-generation protective coatings and specialized elastomers. Industry compliance standards
Typical usage ratio
Downstream process integration
Final product types
|
Competitive 3-(Trifluoromethyl)Benzamidoxime prices that fit your budget—flexible terms and customized quotes for every order.
For samples, pricing, or more information, please call us at +8615371019725 or mail to admin@sinochem-nanjing.com.
We will respond to you as soon as possible.
Tel: +8615371019725
Email: admin@sinochem-nanjing.com
Flexible payment, competitive price, premium service - Inquire now!
Years of hands-on synthesis often teach what textbooks overlook: a compound’s real value shows up in the production line, not just on paper. 3-(Trifluoromethyl)Benzamidoxime stands out in our catalog, not because it’s trendy, but because we’ve watched its qualities play out through demanding projects and challenging customer goals. Our team crafts it in-house, following a route we refined until runs delivered the same purity batch after batch—even under the variability that shows up during winter humidity or those unpredictable summer spikes.
Many researchers and formulation chemists remember their first encounter with trifluoromethyl-substituted benzenes, and how the CF3 group transforms an otherwise familiar scaffold. Our product carries this essential motif at the meta position, resulting in a structure that behaves uniquely under various synthesis conditions. Over years in the plant, we've observed how this compound handles oxidation, reduction, and halogenation reactions—a nuanced performance profile that helps keep processes both robust and reproducible.
We produce 3-(Trifluoromethyl)Benzamidoxime using a proprietary process that keeps byproducts in check and impurity levels low—something our analytical team verifies with HPLC and NMR every single batch. Purity typically exceeds 98%, and we control moisture within tight margins. Mol. formula of C8H7F3N2O, appearance as a pale solid, and melting point characterization give chemists confidence before even opening a drum. Since we scale up from pilot to plant volumes ourselves, we encounter the same scale-up surprises that purchasers do—which means adjustments for real-world plant performance, not just microgram yields from a literature prep.
We don’t simply spec out numbers in a data sheet. Each shipment reflects adjustments made through on-site troubleshooting: batch drying times tweaked to reduce clumping, filtration steps modified for faster flow in cold seasons, particle sizing tuned for faster dissolving during end-user reactions. Instead of remote procurement, our chemists monitor each procedural step, giving direct feedback to production so that end product fits tough downstream applications.
Anyone who’s walked through a working R&D department sees how a benzimidoxime core opens up plenty of derivatization options. Medicinal chemists appreciate the reactivity window it brings when building new classes of pharmaceuticals—especially for compounds aimed at modulating enzyme activity or targeting oxidative pathways. The trifluoromethyl group, with its strong electron-withdrawing ability, frequently fine-tunes biological profiles and metabolic stability.
Synthetic organic chemists draw on it as a reliable precursor for heterocycle construction, particularly in areas involving pyridines, quinolines, or isoxazoles. Our customer base often provides feedback after reactions such as cyclizations or cross-couplings. 3-(Trifluoromethyl)Benzamidoxime’s performance stands out by delivering consistent yields, cleaner separations, and minimal byproduct staining on TLC plates—a feedback loop between our production team and their results has helped us dial in the process.
Industrial-scale processes often press for throughput and fine control. Our compound’s solubility profile, usually a sticking point with other CF3-benzenes, gets noticed by teams needing rapid workup. Our trials showed that process waste drops off noticeably compared to less refined competition—a point of pride for our operations staff, who prioritize responsible chemical stewardship.
Plenty of chemical manufacturers offer amidoxime derivatives, but the field narrows with trifluoromethyl substitution. We see suppliers cut corners by pushing out technical grades bulked with unreacted starting material, tars, or unknowns. From what we've observed during industry audits and competitor sample swaps, uncontrolled side products introduce headaches on both analytical and regulatory fronts—extra peaks in chromatograms, inconsistent reactivity, and lower confidence in scale-up.
Our production team decided early on to invest in dedicated purification steps. Instead of relying solely on crystallization, we reinforce each run with column passes to chase out persistent impurities. This shows up directly in cleaner characterization—sharp melting points, well-resolved NMR signals without ghost peaks, and UV spectra with baseline stability. The feedback we hear from synthetic chemists echoes this: easier analytics, fewer column reruns, and more predictable process transfer.
We’ve run the numbers on impurity profiles and found a direct relationship between careful quality-driven manufacturing and downstream reaction success rates. In contrast, generic amidoximes sourced from traders or bulk resellers often require repurification or fail to meet threshold tests. Those bottlenecks delay important projects and eat up both time and budget—a cycle we've aimed to break.
As a direct manufacturer, every step from raw materials through to final packout runs under our watchful eye. We give priority to operator safety and environmental responsibility—not out of obligation, but from recognizing real-world consequences. Our staff faces the same odors, the same potential slipups, the same paperwork as anyone in the plant. Through practice, we've built systems that catch problems early, from well-tested exhaust lines to in-line monitoring for off-spec reactions.
Disposal and process waste aren’t hidden line items—we tackle them head-on. In the case of 3-(Trifluoromethyl)Benzamidoxime, our improved crystallization reduces mother liquor volume and overall chemical load, while solvent recycling helps keep volatile organic emissions in compliance and plant air fresh. We've swapped notes directly with regulatory officers and site safety professionals to find out what compliance means on the ground—not just in a folder.
Orders don't move through a faceless workflow for us. We hear directly from the chemists and process engineers using our products, and they don’t hold back with their insights. We remember a case where a client repeatedly struggled with clogs and filtration failures using an imported grade. After comparing our product’s filtration profile, they cut their batch times by 30%, triggering a review of process improvements across several sites.
Some clients working on pilot-scale set-ups want to push concentration levels further to maximize throughput and cost savings. On examining repeated feedback from both pharmaceutical and agrochemical sectors, we tuned crystal size and moisture specs. By keeping particle distribution consistent, we help teams avoid the ‘slurry’ issues that bog down automated reactors. It serves as a reminder to us: active listening leads to product refinement.
From dozens of competitor analysis sessions and comparative syntheses, our in-house team documented noticeable differences. Generic sources often bring in variable trace contaminants, from alkali residues to unreacted nitriles. Each extra impurity leads to non-reproducible yields or headaches during final-stage isolation. Our controlled process outputs a compound that brings welcomed predictability to complex syntheses.
Another marked advantage lies in the consistency between batches. Production lots don’t suffer from the day-to-day swings common in facilities with less control over raw inputs or energy supply variations. We commit to sourcing high-purity raw reagents, and regular plant upgrades match advances in analytical technology. The upshot is a product with traceable lot histories and certificates that actually mean something, grounded in tangible plant realities.
Storage stability amounts to more than a number at room temperature. During shelf-life trials and real-life warehousing, our product holds color and dissolves just as smoothly after nine or twelve months—key for customers needing predictable feedstock for long lead-time projects.
Market demand for high-purity trifluoromethylated intermediates keeps ticking upward, driven by both pharmaceutical innovation and the need for selective functionalization in chemical process development. We've seen firsthand how a small impurity profile can spell success or delay during regulatory review of active pharmaceutical ingredients or contract manufacturing runs. Rather than chasing commodity pricing wars, we aim to offer performance and reliability that lowers overall project risk.
Feedback from industry consortia suggests scrutiny continues to rise for every upstream ingredient—especially CF3-containing intermediates—because downstream supply chain confidence increasingly factors into project approval and pharma audit clearance. Our role as a manufacturer puts us directly in the hot seat, so we've leaned into standards that anticipate, not just respond to, these regulatory realities.
In our opinion, supply partners who invest in deeper partnerships, transparency, and technical responsiveness—not just price negotiation—help customers realize wins that show up in final product success. For us, it goes back to the shop floor, where each tweak or improvement ripples out to the people actually pushing molecules forward for human use.
Process impurities create delays and yield losses. We have seen this play out many times after benchmarking new sources or onboarding clients disappointed by off-brand purchases. Motivated by this real-world friction, we maintain extra QC checkpoints—not just at final packaging, but in-process. These layered protections catch drift in solubility, melting point, or unexpected coloration before shipping.
Downtime from clumping or caking poses a known issue for chemists working in humid or fluctuating climates. Through a cycle of continuous feedback, we adapted drying and packaging controls, reducing incidences of clogged reactors or stuck transfer lines. We share these improvements openly with customers, noting storage suggestions or special handling requirements if heat or humidity poses a seasonal concern.
Scale-up rarely proceeds as a neat sequence. During development pilots, we observed side reactions exacerbated by residual moisture or process-variant byproducts. In response, we strengthened process controls upstream and provided supporting technical documentation alongside each shipment, so troubleshooting does not fall entirely on the user.
Our staff handles the same materials, moves the same drums, and sets up the same batch runs as the end users. Through countless preps, we've noticed how operator intuition—timing a filtration, watching for subtle shifts in product color—often heads off problems before they register in QC numbers. Training runs for new hires focus on these experiences, so the next generation trusts their instincts as well as their instruments.
Breaking down process data each month, we noticed longer-than-expected crystal settling times during cooler weather, leading to further process insulation and increased batch tracking during seasonal transitions. Such discoveries stay looped directly into plant planning, not shelved as academic side notes.
Synthetic chemistry always courts unpredictability, yet controlled manufacturing narrows the gap between intent and outcome. Our approach keeps front-line chemists involved in each upgrade, drawing on years at the bench and in production—anchors against both transient trends and external disruptions.
Our experience as the actual manufacturer reinforces the importance of clarity, reliability, and open conversation with all end users. Updates on quality improvements, process modifications, or analytical advances reach the customer as soon as they impact the product, building mutual trust. This dialogue evolves into a relationship where troubleshooting, upgrading specs, and understanding the needs on both sides form the basis for long-term success.
Our production notes stay available, and we share what we see in evolving regulatory or customer-driven demands. Sourcing from a primary producer opens channels for collaboration that can adapt to project pivots or unforeseen hurdles.
The science keeps marching forward, and so do we. Each year, new catalytic technologies shift the bar for reactivity and selectivity; our job pivots to match these with continual improvements to our product. Looking ahead, we anticipate tighter purity requirements, aggressive timelines, and cross-disciplinary applications. Direct engagement with active researchers keeps our roadmap relevant.
By listening to customer labs and integrating lessons from daily manufacturing, we stay committed to turning 3-(Trifluoromethyl)Benzamidoxime into a standard-bearer for reliability and performance in synthetic chemistry. Practical experience, combined with a willingness to keep learning, keeps both our product and team ready for what's next in chemical innovation.